Barostim Therapy: A cost-effective treatment for patients with drug resistant …
CVRx, Inc., a privately held medical device company, today announced findings from a health-economic analysis published in the Journal of Hypertension that indicates Barostim Therapy is a cost-effective treatment option for patients with drug resistant …
Read more on News-Medical.net

Southern California Drug Rehab Offers 30 Day No-Cost Treatment
Aimed at providing high-end substance abuse treatment for those otherwise deterred by the common high costs associated with this level of care, the 60/90 program makes available their well-regarded 90-day inpatient program for the price of 60. Its …
Read more on PR Web (press release)